WHO ICTRP trial
Clinical study of trotansetron combined with dexamethasone or dexmedetomidine in…
ChiCTR2200061360 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200061360 |
|---|---|
| Public title | Clinical study of trotansetron combined with dexamethasone or dexmedetomidine in prevention of postoperative nausea and vomiting in high-risk PONV patients after VATS |
| Scientific title | Clinical study of trotansetron combined with dexamethasone or dexmedetomidine in prevention of postoperative nausea and vomiting in high-risk PONV patients after VATS |
| Primary sponsor | West China Hospital of Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Lung Tumor |
| Interventions | Control Group:Tropisetron was given 5 mg before the end of the operation;dexamethasone Group :Dexamethasone 5 mg was induced and Tropisetron 5 mg was given before the end of operation;dexmedetomidine group:Intraoperative intravenous… |
| Registration date | Jun 21, 2022 |
| Target size | Control Group:70;dexamethasone Group :70;dexmedetomidine group:70 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: